Profound Medical: TULSA shows superior penile length preservation vs robotic prostatectomy in CAPTAIN trial

Profound Medical reported that whole-gland TULSA preserved penile length at 1 month versus a 0.65 cm median reduction after robotic radical prostatectomy.Key Highlights:Original SEC Filing: Profound Medical Corp. [ PROF ] - 8-K - Jul. 24, 2026This is an AI-powered summary. It may contain inaccuraci…

Profound Medical reported that whole-gland TULSA preserved penile length at 1 month versus a 0.65 cm median reduction after robotic radical prostatectomy.

Key Highlights:

CAPTAIN Level 1 post-market RCT shows no median change in penile length at 1 month after whole-gland TULSA vs 0.65 cm reduction after robotic RP.
Mixed-effects model found a statistically significant between-arm difference in penile length change of 0.42 cm (p<0.001).
Findings presented at the Society of Robotic Surgery annual meeting by Xiaosong Meng, MD, PhD.
Builds on prior CAPTAIN results where TULSA showed superior preservation of erectile function and urinary continence at 6 months.

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.